NCT02143804 2026-04-02
exBOND
CG Oncology, Inc.
Phase 2 Withdrawn
Clinical Trials
6 trialsNCT02532452 2025-12-16
Third Party Viral Specific T-cells (VSTs)
Children's Hospital Medical Center, Cincinnati
Phase 2 Recruiting
NCT04673942 2024-10-26
BETA-PRIME
EpicentRx, Inc.
Phase 2 Recruiting
NCT04739046 2021-03-17
An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy
Seoul National University Bundang Hospital
Phase 2 Unknown
NCT03190824 2019-04-16
Evaluate Efficacy, Immunological Response of Intratumoral/Intralesional Oncolytic Virus (OBP-301) in Metastatic Melanoma
Syneos Health
Phase 2 Unknown
NCT00116363 2008-04-01
Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma
Introgen Therapeutics
Phase 2 Unknown